Financial statements Psi Pharma Support Poland
Balance sheet data of PSI PHARMA SUPPORT POLAND
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 20 234 855,49 | 20 435 060,67 | 73 432 406,38 | 74 372 602,48 | 76 957 401,45 | 79 101 571,14 |
| A. Fixed assets | 17 764 161,85 | 724 948,40 | 67 894 283,39 | 70 646 923,87 | 68 374 737,86 | 66 490 173,67 |
| B. Current assets | 2 470 693,64 | 19 710 112,27 | 5 538 122,99 | 3 725 678,61 | 8 582 663,59 | 12 611 397,47 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 20 234 855,49 | 20 435 060,67 | 73 432 406,38 | 74 372 602,48 | 76 957 401,45 | 79 101 571,14 |
| A. Equity | 18 948 362,19 | 19 286 265,34 | 72 658 624,81 | 73 750 794,49 | 74 478 363,22 | 76 162 770,84 |
| B. Liabilities and provisions for liabilities | 1 286 493,30 | 1 148 795,33 | 773 781,57 | 621 807,99 | 2 479 038,23 | 2 938 800,30 |
| I. Long-term liabilities | 0,00 | 30 000,00 | 40 000,00 | 58 000,00 | 469 564,26 | 381 592,48 |
| II. Short-term liabilities | 844 806,50 | 708 382,08 | 163 336,21 | 212 191,61 | 1 544 903,35 | 2 053 692,04 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.